CHRNA2 and Nocturnal Frontal Lobe Epilepsy: Identification and Characterization of a Novel Loss of Function Mutation
Chiara Villa,Giulia Colombo,Simone Meneghini,Cecilia Gotti,Milena Moretti,Luigi Ferini-Strambi,Elisa Chisci,Roberto Giovannoni,Andrea Becchetti,Romina Combi
DOI: https://doi.org/10.3389/fnmol.2019.00017
2019-02-12
Frontiers in Molecular Neuroscience
Abstract:Mutations in genes coding for subunits of the neuronal nicotinic acetylcholine receptor (nAChR) have been involved in familial sleep-related hypermotor epilepsy (also named autosomal dominant nocturnal frontal lobe epilepsy, ADNFLE). Most of these mutations reside in <i>CHRNA4</i> and <i>CHRNB2</i> genes, coding for the α4 and β2 nAChR subunits, respectively. Two mutations with contrasting functional effects were also identified in the <i>CHRNA2</i> gene coding for the α2 subunit. Here, we report the third mutation in the <i>CHRNA2</i>, found in a patient showing ADNFLE. The patient was examined by scalp EEG, contrast-enhanced brain magnetic resonance imaging (MRI), and nocturnal video-polysomnographic recording. All exons and the exon-intron boundaries of <i>CHRNA2</i>, <i>CHRNA4</i>, <i>CHRNB2</i>, <i>CRH</i>, <i>KCNT1</i> were amplified and Sanger sequenced. In the proband, we found a c.754T>C (p.Tyr252His) missense mutation located in the N-terminal ligand-binding domain and inherited from the mother. Functional studies were performed by transient co-expression of α2 and α2 <sup><i>Tyr</i>252<i>His</i></sup> , with either β2 or β4, in human embryonic kidney (HEK293) cells. Equimolar amounts of subunits expression were obtained by using F2A-based multi-cistronic constructs encoding for the genes relative to the nAChR subunits of interest and for the enhanced green fluorescent protein. The mutation reduced the maximal currents by approximately 80% in response to saturating concentrations of nicotine in homo- and heterozygous form, in both the α2β4 and α2β2 nAChR subtypes. The effect was accompanied by a strong right-shift of the concentration-response to nicotine. Similar effects were observed using ACh. Negligible effects were produced by α2<sup>Tyr252His</sup> on the current reversal potential. Moreover, binding of (±)-[<sup>3</sup>H]Epibatidine revealed an approximately 10-fold decrease of both K<sub>d</sub> and B<sub>max</sub> (bound ligand in saturating conditions), in cells expressing α2<sup>Tyr252His</sup>. The reduced B<sub>max</sub> and whole-cell currents were not caused by a decrease in mutant receptor expression, as minor effects were produced by α2<sup>Tyr252His</sup> on the level of transcripts and the membrane expression of α2β4 nAChR. Overall, these results suggest that α2<sup>Tyr252His</sup> strongly reduced the number of channels bound to the agonist, without significantly altering the overall channel expression. We conclude that mutations in <i>CHRNA2</i> are more commonly linked to ADNFLE than previously thought, and may cause a loss-of-function phenotype.
neurosciences